Segmed, a Palo Alto-based provider of real-world imaging data, raised $10.4M in Series A funding.

The round was led by iGan Partners and Advocate Health, joined by Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, Y Combinator, and others.

The funds will be used to expand Segmed's medical imaging solutions for AI development and real-world evidence.

Led by CEO Martin Willemink, Segmed partners with healthcare firms to streamline access to imaging data for biopharmaceutical R&D and global health initiatives.

This Series A follows earlier financing from Flashpoint Growth Debt Fund in 2023.